EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
29 hedge funds and large institutions have $14M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
29
Holding in Top 10
3
Calls
$60K
Puts
–
Top Buyers
| 1 | +$110K | |
| 2 | +$86.8K | |
| 3 | +$15.7K | |
| 4 |
EWA
EP Wealth Advisors
Torrance,
California
|
+$11.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.52K |
Top Sellers
| 1 | -$592K | |
| 2 | -$197K | |
| 3 | -$67.7K | |
| 4 |
HF
HRT Financial
New York
|
-$25K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$23.9K |